Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Cash & Equivalents

$517.00M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Cash & Equivalents

Latest reported$517.00Mperiod endingJun 30, 2026

BIO Quarterly Cash & Equivalents ($6.00M → $517.00M)

Quarterly Cash & Equivalents

High-resolution chart · PNG

BIO cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Cash & Equivalents — Quarterly (USD)
Period ending	Cash & Equivalents (USD)
Jun 30, 2026	517,000,000
Mar 31, 2026	507,200,000
Dec 31, 2025	531,799,999
Sep 30, 2025	397,800,000
Jun 30, 2025	369,300,000
Mar 31, 2025	521,400,000
Dec 31, 2024	488,100,000
Sep 30, 2024	410,377,000
Jun 30, 2024	406,913,000
Mar 31, 2024	433,280,000
Dec 31, 2023	403,815,000
Sep 30, 2023	457,850,000
Jun 30, 2023	390,001,000
Mar 31, 2023	464,136,000
Dec 31, 2022	434,215,000
Sep 30, 2022	517,943,000
Jun 30, 2022	596,584,000
Mar 31, 2022	802,316,000
Dec 31, 2021	470,783,000
Sep 30, 2021	859,902,000
Jun 30, 2021	732,836,000
Mar 31, 2021	673,470,000
Dec 31, 2020	662,205,000
Sep 30, 2020	840,325,000
Jun 30, 2020	607,584,000
Mar 31, 2020	603,551,000
Dec 31, 2019	660,672,000
Sep 30, 2019	561,071,000
Jun 30, 2019	580,684,000
Mar 31, 2019	455,890,000
Dec 31, 2018	431,526,000
Sep 30, 2018	434,517,000
Jun 30, 2018	403,006,000
Mar 31, 2018	407,272,000
Dec 31, 2017	383,824,000
Sep 30, 2017	328,894,000
Jun 30, 2017	321,584,000
Mar 31, 2017	291,663,000
Dec 31, 2016	456,264,000
Sep 30, 2016	417,939,000
Jun 30, 2016	418,651,000
Mar 31, 2016	403,615,000
Dec 31, 2015	457,549,000
Sep 30, 2015	507,329,000
Jun 30, 2015	450,133,000
Mar 31, 2015	425,728,000
Dec 31, 2014	413,251,000
Sep 30, 2014	424,593,000
Jun 30, 2014	384,670,000
Mar 31, 2014	364,507,000
Dec 31, 2013	331,551,000
Sep 30, 2013	291,793,000
Jun 30, 2013	366,999,000
Mar 31, 2013	368,629,000
Dec 31, 2012	463,388,000
Sep 30, 2012	426,457,000
Jun 30, 2012	456,487,000
Mar 31, 2012	533,812,000
Dec 31, 2011	574,231,000
Sep 30, 2011	671,028,000
Jun 30, 2011	670,301,000
Mar 31, 2011	627,908,000
Dec 31, 2010	906,551,000
Sep 30, 2010	630,640,000
Jun 30, 2010	614,223,000
Mar 31, 2010	598,134,000
Dec 31, 2009	649,938,000
Sep 30, 2009	554,179,000
Jun 30, 2009	533,474,000
Mar 31, 2009	192,870,000
Dec 31, 2008	204,524,000
Sep 30, 2008	193,627,000
Jun 30, 2008	183,643,000
Mar 31, 2008	129,480,000
Dec 31, 2007	161,764,000
Sep 30, 2007	472,792,000
Jun 30, 2007	232,403,000
Mar 31, 2007	230,314,000
Dec 31, 2006	223,607,000
Sep 30, 2006	238,418,000
Jun 30, 2006	245,646,000
Mar 31, 2006	265,587,000
Dec 31, 2005	296,716,000
Sep 30, 2005	243,980,000
Jun 30, 2005	252,132,000
Mar 31, 2005	317,898,000
Dec 31, 2004	195,734,000
Sep 30, 2004	125,154,000
Jun 30, 2004	155,329,000
Mar 31, 2004	141,548,000
Dec 31, 2003	65,395,000
Sep 30, 2003	140,748,000
Jun 30, 2003	28,828,000
Mar 31, 2003	25,223,000
Dec 31, 2002	27,733,000
Sep 30, 2002	39,250,000
Jun 30, 2002	25,655,000
Mar 31, 2002	44,946,000
Dec 31, 2001	47,129,000
Sep 30, 2001	32,326,000